Clinical Trials Directory

Trials / Completed

CompletedNCT05282992

NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort

A Randomized, Double-blind, Placebo-controlled Study to Evaluate Efficacy and Tolerability of a Food Supplement in Healthy Volunteers With Joint Discomfort

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
75 (actual)
Sponsor
Bioiberica · Industry
Sex
All
Age
30 Years – 65 Years
Healthy volunteers
Accepted

Summary

Collagen Supplement is a natural ingredient that contains native collagen derived from chicken sternum. Collagen Supplement is efficacious and safe on healthy subjects as compared to placebo.

Detailed description

This study will include 100 healthy volunteers in which will be evaluated if the collagen supplement is able to obtain differences versus placebo in pain and function. It will be a randomized, double-blind, placebo-controlled study with proportion 1:1 between treatments

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNative type II collagen1 capsule/day
DIETARY_SUPPLEMENTPlacebo1 capsule/day

Timeline

Start date
2022-03-03
Primary completion
2023-11-14
Completion
2024-03-18
First posted
2022-03-16
Last updated
2024-08-29

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05282992. Inclusion in this directory is not an endorsement.

NAtive Collagen Type II In Healthy VoluntEers With Joint Discomfort (NCT05282992) · Clinical Trials Directory